Evidence Level:Sensitive: A2 - Guideline
Title:
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
Excerpt:Carboplatin may be offered as part of a neoadjuvant regimen in patients with TNBC to increase likelihood of pCR.
DOI:10.1200/JCO.20. 03399